Certain published study results have found that LLLT can cause negative reactions when an inappropriate choice of light source or an inappropriate dosage is used. There is an optimal dose of light for any particular application, and in the case of red light therapy, often lower doses are found to be more effective than higher doses. Be sure to work with a qualified LLLT practitioner whenever receiving treatments, and report any side effects, including burning, swelling, dizziness, muscle weakness or nausea. Keep in mind that seeing results from red light treatments might take patience and that responsiveness is expected to vary.
References : 1. LYMPHOSEEK Injection [prescribing information]. Dublin, OH: Cardinal Health; June 2017. 2. Sondak V, King DW, Zager JS, et al. Combined analysis of Phase III trials evaluating Tc99m tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann Surg Oncol . 2013;20:680-8. 3. Wallace AM, Han LK, Povoski SP, et al. Comparative evaluation of [99mTc] tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two Phase 3 trials. Ann Surg Oncol . 2013; doi /s10434-013-2887-8. 4. Vera, DR, Tokin CA. Tilmanocept: a synthetic receptor-targeted molecule for sentinel lymph node mapping. International Atomic Energy Agency (IAEA) Publication 2014; Chapter X: In Press.